Abstract: A cage in which is mounted a plurality of horizontal bars allowing to insert a reducer of space that is connected by a fastening mean and fixed under an insulating panel situated at the top of the cage, and that is manually displaced above the frozen foods for reducing the space preserving the frozen foods and the use of ice bags or dry ice. The reducer of space is formed with a frame in which is mounted a rigid sheet, a rubber foam and a vapor barrier.

Abstract: A cage in which is mounted a reducer of cold room that can be manually raised and blocked during the loading or unloading of the goods, and that automatically slopes down above the frozen foods when the door is closed for reducing the space preserving the frozen foods either by using the ice bags or dry ice during the delivery of the frozen foods.

Abstract: A cage in which is mounted a reducer of cold room that can be manually raised and blocked during the loading or unloading of the goods, and that automatically slopes down above the frozen foods when the door is closed for reducing the space preserving the frozen foods either by using the ice bags or dry ice during the delivery of the frozen foods.

Abstract: An improved magnesium die casting system incorporates filling of the shot sleeve from the underside and/or in-line re-melting of scrap magnesium using a re-melt furnace. A pump is used to transfer molten magnesium from a casting furnace to the shot sleeve through an underflow filling tube. The shot sleeve is filled in a laminar manner, minimizing entrapped gases. The in-line re-melt system allows recycling of scrap in-house and reduces energy cost associated with heating and re-heating scrap. The improved system increases casting quality and reduces scrap rates and recycling costs.

Abstract: A stereoselective process for the industrial synthesis of compounds of formula (I): wherein R represents linear or branched (C1-C6)alkyl, and application in the synthesis of perindopril and pharmaceutically acceptable salts thereof.

Abstract: An improved magnesium die casting system incorporates filling of the shot sleeve from the underside and/or in-line re-melting of scrap magnesium using a re-melt furnace. A pump is used to transfer molten magnesium from a casting furnace to the shot sleeve through an underflow filling tube. The shot sleeve is filled in a laminar manner, minimizing entrapped gases. The in-line re-melt system allows recycling of scrap in-house and reduces energy cost associated with heating and re-heating scrap. The improved system increases casting quality and reduces scrap rates and recycling costs.

Abstract: An auger pump for pumping molten magnesium and its alloys from a furnace to a die casting machine, ingot mould, DC caster or the like is disclosed. The pump is comprised of a linearly aligned upper and lower portion. The upper portion is comprised of a housing which is attached to the furnace lid. An inverter duty electric motor is attached to the top of the housing and is controlled by a PLC. The auger shaft runs longitudinally between each portion and is supported in position by guide bearings located in the upper portion. The lower portion comprises a tubular casing which contains a gas inlet aperture and an feeder inlet aperture for drawing the molten magnesium into the pump. The outlet of the pump, a connector, is attached to a heated transfer tube, which conveys the molten magnesium to the mould.

Abstract: Stereoselective process for the industrial synthesis of compounds of formula (I): 1

Abstract: A composition comprising a protein having an inhibitory activity for a serine protease and, in particular, for a serine elastase, the protein having a molecular weight of about 46 kDa in a deglycosylated form, and having a molecular weight of about 54 kDa when isolated in a glycosylated form is provided. Methods of using the protein in treatments of diseases where inhibition of a serine protease and, in particular, of a serine elastase is effective are provided as well as compositions, reagents, and kits related thereto.

Abstract: This invention relates to an improved mould for casting a standard Magnesium ingot. The mould is constructed so as to minimize the surface area of the molten Magnesium which is exposed to the surrounding air. This significantly reduces the reliance on costly or harmful gases typically used in the casting process. The vertical mould which is internally tapered, has an open top and a closure at the bottom thereof. The ingot is easily removed from the mould when said closure is opened. The mould is adapted for use as part of an automated process employing a cyclic conveyance system for efficiently producing Magnesium ingots from recycled scrap Magnesium.

Abstract: An auger pump for pumping molten magnesium and its alloys from a furnace to a die casting machine, ingot mould, DC caster or the like is disclosed. The pump is comprised of a linearly aligned upper and lower portion. The upper portion is comprised of a housing which is attached to the furnace lid. An inverter duty electric motor is attached to the top of the housing and is controlled by a PLC. The auger shaft runs longitudinally between each portion and is supported in position by guide bearings located in the upper portion. The lower portion comprises a tubular casing which contains a gas inlet aperture and an feeder inlet aperture for drawing the molten magnesium into the pump. The outlet of the pump, a connector, is attached to a heated transfer tube, which conveys the molten magnesium to the mould.

Abstract: The present invention relates to the use of the compounds of formula: ##STR1## in which R.sub.1 is a linear, branched or cyclized C.sub.1 -C.sub.5 alkyl radical andR.sub.2 represents a hydrogen atom, a linear or branched C.sub.1 -C.sub.5 alkyl radical, a hydroxyl radical, a C.sub.1 -C.sub.5 alkoxy radicalor a C.sub.1 -C.sub.2 hydroxyalkyl radical, andR.sub.3 represents a hydrogen atomor R.sub.2 and R.sub.3 both represent a C.sub.1 -C.sub.5 alkyl radical,these compounds being 2R in configuration, as well as of the racemates comprising these compounds, and of their pharmaceutically acceptable salts, for the manufacture of a medicament intended for the treatment of pain of visceral origin.

Abstract: Novel N-cyclohexylbenzamide derivatives of formula: ##STR1## where R.sub.1 represents an alkoxy radical capable of cyclizing with the aromatic ring;R.sub.2, R.sub.3 and R.sub.4 each independently represent hydrogen, a halogen or an alkoxy, amino, alkylamino or alkyl-carbonylamino group, andZ represents a differently substituted piperidinyl group; and their addition salts with pharmaceutically acceptable acids.The compounds of formula I are powerful gastrointestinal motility stimulants.

Abstract: Compounds of general formula I ##STR1## wherein: X represents oxygen or sulphur; each of R.sup.1 and R.sup.3 independently represents hydrogen or a C.sub.1 -C.sub.4 alkyl group;Ar represents:a phenyl ring optionally substituted by one, two or three C.sub.1 -C.sub.4 alkoxy groups and/or by one or two halogen atoms;a phenyl ring of the general formula ##STR2## wherein R.sup.2 represents halogen, 4,5-benzo, C.sub.1 -C.sub.8 alkoxy, C.sub.1 -C.sub.4 alkylcarbonyl or Am, wherein Am represents amino, methylamino or dimethylamino,R.sup.4 represents C.sub.1 -C.sub.8 alkyl,n is 1 or 2; ora pyrimidinyl moiety of the general formula ##STR3## wherein R.sup.5 is C.sub.1 -C.sub.4 alkyl; and their N-oxides and pharmaceutically acceptable salts are useful as anxiolytic agents. A preferred compound is R-(+)-4-amino-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxybenzamide.

Abstract: The present invention relates to compounds of formula: ##STR1## in which: R.sub.3 is hydrogen, 2-tetrahydropyranyl or benzyl;R.sub.1 and R.sub.2 are such that:either R.sub.1 represents a methoxy group in which case R.sub.2 is a group chosen from the following: hydroxyl; C.sub.1 -C.sub.4 alkyl; C.sub.2 -C.sub.8 alkyloxy; C.sub.5 -C.sub.7 cycloalkloxy; benzyloxy;or R.sub.2 represents a methoxy group in which case R.sub.1 is a group chosen from the following: hydroxyl; C.sub.2 -C.sub.8 alkyloxy; C.sub.2 -C.sub.8 alkyloxy substituted by a methoxy group; C.sub.1 -C.sub.4 trifluoroalkyloxy; C.sub.3 -C.sub.4 alkenyloxy; C.sub.5 -C.sub.7 cycloalkyloxy; benzyloxy; C.sub.1 -C.sub.4 alkylthio;n=2 or 3; andp=4, 5 or 6,as well as their addition salts with mineral or organic acids, said compounds and salts being useful as drugs.

Abstract: Compounds of general formula I ##STR1## wherein: X represents oxygen or sulphur;each of R.sup.1 and R.sup.3 independently represents hydrogen or a C.sub.1 -C.sub.4 alkyl group;Ar represents:a phenyl ring optionally substituted by one, two or three C.sub.1 -C.sub.4 alkoxy groups and/or by one or two halogen atoms; a phenyl ring of the general formula ##STR2## wherein R.sup.2 represents halogen, 4,5-benzo, C.sub.1 -C.sub.8 alkoxy, C.sub.1 -C.sub.4 alkylcarbonyl or Am, wherein Am represents amino, methylamino or dimethylamino,R.sup.4 represents C.sub.1 -C.sub.8 alkyl,n is 1 or 2; ora pyrimidinyl moiety of the general formula ##STR3## wherein R.sup.5 is C.sub.1 -C.sub.4 alkyl; and their N-oxides and pharmaceutically acceptable salts are useful as antischizophrenic and/or antipsychotic agents. A preferred compound is S(-)-4-amino-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxybenzamide.

Abstract: Compounds of general formula I ##STR1## wherein: X represents oxygen or sulphur;each of R.sup.1 and R.sup.3 independently represents hydrogen or a C.sub.1 -C.sub.4 alkyl group;Ar represents:a phenyl ring optionally substituted by one, two or three C.sub.1 -C.sub.4 alkoxy groups and/or by one or two halogen atoms; a phenyl ring of the general formula ##STR2## wherein R.sup.2 represents halogen, 4,5-benzo, C.sub.1 -C.sub.8 alkoxy, C.sub.1 -C.sub.4 alkylcarbonyl or Am, wherein Am represents amino, methylamino or dimethylamino,R.sup.4 represents C.sub.1 -C.sub.8 alkyl,n is 1 or 2; ora pyrimidinyl moiety of the general formula ##STR3## wherein R.sup.5 is C.sub.1 -C.sub.4 alkyl; and their N-oxides and pharmaceutically acceptable salts are useful as memory- and/or learning-enhancing agents. A preferred compound is R-(+)-4-amino-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxybenzamide.

Abstract: The present invention relates to compounds of formula: ##STR1## in which: R.sub.1 and R.sub.2 are such that:either R.sub.1 represents a methoxy group in which case R.sub.2 is a group chosen from the following: hydroxyl; C.sub.1 -C.sub.4 alkyl; C.sub.2 -C.sub.8 alkyloxy; C.sub.5 -C.sub.7 cycloalkyloxy; benzyloxy;or R.sub.2 represents a methoxy group in which case R.sub.1 is a group chosen from the following: hydroxyl; C.sub.2 -C.sub.8 alkyloxy; C.sub.2 -C.sub.8 alkyloxy substituted by a methoxy group; C.sub.1 -C.sub.4 trifluoroalkyloxy; C.sub.3 -C.sub.4 alkenyloxy; C.sub.5 -C.sub.7 cycloalkyloxy; benzyloxy; C.sub.1 -C.sub.4 alkyhlthio;n=2 or 3; andp=4, 5 or 6,as well as their addition salts with mineral or organic acids, said compounds and salts being useful as drugs.